An observational study in Hyperthyroidism, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Assiut University · Observational
To evaluate the effect of subclinical and overt Hyperthyroidism in renal function
Thyroid disorders are very common with a high prevalence among the general population. Thyroid diseases are associated with many detrimental effects that have a serious impact on various body systems.(1)
Several mechanisms were found playing roles on increasing both the size and functional capacity of kidney:
Although the mechanistic link between thyroid and kidney disease remains unclear, hyperthyroidism may have significant effect on renal function
112 studies on the registry are indexed under Hyperthyroidism; 27 are open to participants now.
This study's planned enrollment of 50 is below the median of 98 across 48 observational studies indexed under Hyperthyroidism.
Browse Hyperthyroidism studies →Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Patients with overt Hyperthyroidism ( clinically manifested and laboratory by low TSH, high fT3 \& fT4) And subclinical hyperthyroidism ( low TSH \<0.4.MI/IU without clinical symptoms of hyperthyroidism
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Evaluation of renal function in patients with subclinical and overt Hyperthyroidism.
Time frame: baseline
No study locations are listed for this record.
Start is estimated for Sep 2024; primary completion for Mar 2026, 18 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.